(Q41057587)

26 September 2017

1 reference

title

The cytokine response to critical illness (English)

1 reference

26 September 2017

Foëx BA

1

1 reference

PMCID

1342677

26 September 2017

Shelly MP

series ordinal

2

1 reference

PMCID

1342677

26 September 2017

language of work or name

1 reference

1 May 1996

1 reference

Journal of accident & emergency medicine

26 September 2017

1 reference

26 September 2017

13

1 reference

26 September 2017

154-162

1 reference

26 September 2017

3

1 reference

Beneficial effects of combined thromboxane and leukotriene receptor antagonism in hemorrhagic shock

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

The gut as source of sepsis after hemorrhagic shock

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid.

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Detection of circulating tumor necrosis factor after endotoxin administration.

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Increased plasma levels of interleukin-6 in sepsis

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

The serum interleukin 6 response to elective surgery.

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Plasma tumor necrosis factor and mortality in critically ill septic patients

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Response of serum interleukin-6 in patients undergoing elective surgery of varying severity.

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways.

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Metabolic and respiratory changes after cholecystectomy performed via laparotomy or laparoscopy

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Circulating interleukin-1 beta and tumor necrosis factor-alpha concentrations after burn injury in humans

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Monoclonal antibodies to tumor necrosis factor in sepsis: help or harm?

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Serum tumor necrosis factor-alpha profile in trauma patients

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Sepsis therapy trials. Continued disappointment or reason for hope?

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Effect of anaesthesia on the cytokine responses to abdominal surgery.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

The HA-1A saga: the scientific and ethical dilemma of innovative and costly therapies.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Evidence favoring the role of the gut as a cytokine-generating organ in rats subjected to hemorrhagic shock.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Effects of extradural anaesthesia on interleukin-6 and acute phase response to surgery.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1342677

Dynamics of interleukin 1, 2, and 6 and tumor necrosis factor alpha in multiple trauma patients

19 August 2018

1 reference

12 December 2020

Continuous infusion of pyridostigmine for myasthenic crisis

1 reference

12 December 2020

Cytokine response to burn injury: relationship with protein metabolism

1 reference

12 December 2020

Temporal patterns of hemodynamics, oxygen transport, cytokine activity, and complement activity in the development of adult respiratory distress syndrome after severe injury

1 reference

12 December 2020

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

1 reference

12 December 2020

Plasma endotoxin and cytokine concentrations in patients with hemorrhagic shock

1 reference

12 December 2020

Effects of trauma, duration of hypotension, and resuscitation regimen on cellular immunity after hemorrhagic shock

1 reference

12 December 2020

A plea for caution in the performance of sepsis trials

1 reference

12 December 2020

The grading of sepsis

1 reference

12 December 2020

Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease

1 reference

12 December 2020

Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans

1 reference

12 December 2020

Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma.

1 reference

12 December 2020

Selective and early increase of IL-1 inhibitors, IL-6 and cortisol after elective surgery

1 reference

12 December 2020

Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin

1 reference

12 December 2020

The release of interleukin-1 beta (IL-1) precedes that of interleukin 6 (IL-6) in patients undergoing major surgery

1 reference

12 December 2020

Inhibition of NO synthesis in septic shock

1 reference

12 December 2020

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group

1 reference

12 December 2020

Cytokines yes, cytokines no, cytokines maybe?

1 reference

12 December 2020

Effects of accidental trauma on cytokine and endotoxin production

1 reference

12 December 2020

Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial

1 reference

12 December 2020

Identifiers

DOI

10.1136/EMJ.13.3.154

1 reference

26 September 2017

1 reference

26 September 2017

1 reference

PMCID

1342677